Provenienza dei contatti di primo grado di Andrew Nebel
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Duchenne UK
Duchenne UK Investment Trusts/Mutual FundsMiscellaneous Duchenne UK is a UK-based charity that focuses on finding effective treatments for Duchenne muscular dystrophy (DMD), a progressive condition that weakens all the muscles in the body and is diagnosed in childhood. Additionally, Duchenne connects and supports families affected by DMD. The charity funds research that aims to provide treatments for those affected by DMD and removes roadblocks that prevent patients from accessing the treatments they need. The British company was founded in 2012 by Nick Crossley, Emily Crossley, and Alex Johnson, and Emily Crossley and Alex Johnson have been the CEOs since 2012.
10
| Non-Profit Organization | Investment Trusts/Mutual Funds | 10 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Andrew Nebel tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Duchenne Research (UK) Investment Ltd.
Duchenne Research (UK) Investment Ltd. BiotechnologyHealth Technology Duchenne Research (UK) Investment Ltd. is a biotechnology research and British experimental development company founded in 2014. The location of the private company is not specified. The company provides services in the field of biotechnology research and development. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
Regno Unito | 2 |
Settori
Health Technology | 2 |
Posizioni
Director/Board Member | 9 |
Founder | 3 |
Chief Executive Officer | 2 |
Contatti più connessi
- Borsa valori
- Insiders
- Andrew Nebel
- Connessioni Società